Authors:
Saves, M
Morlat, P
Chene, G
Peuchant, E
Pellegrin, I
Bonnet, F
Bernard, N
Lacoste, D
Salamon, R
Beylot, J
Citation: M. Saves et al., Prognostic value of plasma markers of immune activation in patients with advanced HIV disease treated by combination antiretroviral therapy, CLIN IMMUNO, 99(3), 2001, pp. 347-352
Authors:
Gentili, M
Enel, D
Szymskiewicz, O
Mansour, F
Bonnet, F
Citation: M. Gentili et al., Postoperative analgesia by intraarticular clonidine and neostigmine in patients undergoing knee arthroscopy, REG ANES PA, 26(4), 2001, pp. 342-347
Authors:
Visseaux, M
Barbier-Baudry, D
Bonnet, F
Dormond, A
Citation: M. Visseaux et al., New viscoelastic materials obtained by insertion of an alpha-olefin in a trans-polyisoprene chain with a single-component organolanthanide catalyst, MACRO CH P, 202(12), 2001, pp. 2485-2488
Authors:
Nouts, C
Bonarek, M
Morlat, P
Delevaux, I
Bonnet, F
Lacoste, D
Bernard, N
Beylot, J
Citation: C. Nouts et al., The absence of hyperbilirubinaemia is highly predictive of treatment failure in advanced HIV-infected patients treated with indinavir, INT J STD A, 12(1), 2001, pp. 29-33
Authors:
Barbier-Baudry, D
Bonnet, F
Dormond, A
Hafid, A
Nyassi, A
Visseaux, M
Citation: D. Barbier-baudry et al., Organolanthanides, catalysts for specific olefin-diene copolymerization: access to new materials, J ALLOY COM, 323, 2001, pp. 592-596
Authors:
Lagneau, F
Benayoun, L
Plaud, B
Bonnet, F
Favier, J
Marty, J
Citation: F. Lagneau et al., The interpretation of train-of-four monitoring in intensive care: what about the muscle site and the current intensity?, INTEN CAR M, 27(6), 2001, pp. 1058-1063
Authors:
Bonnet, F
Deprele, C
Sassolas, A
Moulin, P
Alamartine, E
Berthezene, F
Berthoux, F
Citation: F. Bonnet et al., Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis, AM J KIDNEY, 37(4), 2001, pp. 720-727
Authors:
Bonnet, F
Saves, M
Droz, C
Peuchant, E
Chene, G
Beylot, J
Morlat, P
Citation: F. Bonnet et al., Increase of lipid plasma concentrations under protease inhibitor-containing regimens are not related to modifications of the tumour necrosis factor system, AIDS, 15(7), 2001, pp. 940-941
Authors:
Bonnet, F
Cooper, ME
Carey, RM
Casley, D
Cao, ZM
Citation: F. Bonnet et al., Vascular expression of angiotensin type 2 receptor in the adult rat: influence of angiotensin II infusion, J HYPERTENS, 19(6), 2001, pp. 1075-1081
Authors:
Cao, ZM
Bonnet, F
Davis, B
Allen, TJ
Cooper, ME
Citation: Zm. Cao et al., Additive hypotensive and anti-albuminuric effects of angiotensin-converting enzyme inhibition and angiotensin receptor antagonism in diabetic spontaneously hypertensive rats, CLIN SCI, 100(6), 2001, pp. 591-599
Authors:
Cao, ZM
Burrell, LM
Tikkanen, I
Bonnet, F
Cooper, ME
Gilbert, RE
Citation: Zm. Cao et al., Vasopeptidase inhibition attenuates the progression of renal injury in subtotal nephrectomized rats, KIDNEY INT, 60(2), 2001, pp. 715-721
Authors:
Bonnet, F
Cooper, ME
Kawachi, H
Allen, TJ
Boner, G
Cao, Z
Citation: F. Bonnet et al., Irbesartan normalises the deficiency in glomerular nephrin expression in amodel of diabetes and hypertension, DIABETOLOG, 44(7), 2001, pp. 874-877
Authors:
Stephan, F
Flahault, A
Dieudonne, N
Hollande, J
Paillard, F
Bonnet, F
Citation: F. Stephan et al., Clinical evaluation of circulating blood volume in critically ill patients- contribution of a clinical scoring system, BR J ANAEST, 86(6), 2001, pp. 754-762
Authors:
Bonnet, F
Neau, D
Viallard, JF
Morlat, P
Ragnaud, JM
Dupon, M
Legendre, P
Imbert, Y
Lifermann, F
Le Bras, M
Beylot, J
Longy-Boursier, M
Citation: F. Bonnet et al., Clinical and laboratory findings of cytomegalovirus infection in 115 hospitalized non-immunocompromised adults, ANN MED IN, 152(4), 2001, pp. 227-235
Authors:
Bonnet, F
Samain, E
Bocquet, R
Le Corre, F
Marty, J
Citation: F. Bonnet et al., Perioperative management of severe head injury in a patient with arrhythmogenic right ventricular dysplasia, ANESTHESIOL, 95(1), 2001, pp. 255-256